EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC

Overview Fund Activity
Delisted

EBAC was delisted on the 2nd of March, 2023.

Back to rankings

50 hedge funds and large institutions have $94M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
–
Holders Change %
0%
% of All Funds
0.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
5
Increased
5
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GCL
Glazer Capital LLC
New York
+$2.62M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.52M
3
MTCM
Mint Tower Capital Management
Netherlands
+$1.01M
4
WP
Woodline Partners
California
+$1.01M
5
RCM
Radcliffe Capital Management
Pennsylvania
+$962K

Top Sellers

1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$3.69M
2
Calamos Advisors
Calamos Advisors
Illinois
-$992K
3
GCM
Ghisallo Capital Management
Massachusetts
-$969K
4
PC
Periscope Capital
Ontario, Canada
-$671K
5
GF
Gabelli Funds
New York
-$112K
Name Holding Trade Value Shares
Change 		Shares
Change %
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
– -$3.69M -496,000 Closed
Calamos Advisors
52
Calamos Advisors
Illinois
– -$992K -100,000 Closed
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
– -$271 -27,325 Closed
AA
54
Ancora Advisors
Ohio
– -$69K -7,000 Closed
1 2
3